The molecule was developed by Frank Ng's group at Monash University and Metabolic Pharmaceuticals in Australia during the 1990s and 2000s as a potential anti-obesity drug intended to isolate the lipolytic region of hGH without activating the growth hormone receptor or raising IGF-1.nnIn published preclinical work, the fragment has been shown to stimulate lipolysis, suppress lipogenesis, and modulate the beta-3 adrenergic receptor pathway in adipose tissue rather than acting through the classical hGH receptor
[DOI] [PubMed] [Google Scholar] 187.Stupnisek M., Franjic S., Drmic D., Hrelec M., Kolenc D., Radic B., Bojic D., Vcev A., Seiwerth S., Sikiric P
Tras la reconstitucin del pptido debe almacenarse a 4 C entre 2-21 das y para el uso futuro por debajo de -18 C
[2] Supplements are commonly taken orally but may be administered via intramuscular injection to treat deficiencies
"Regeneration or Risk